alpha-feto protein ( alpha-fp ) is now accepted as a very useful serum marker of hepatocarcinoma , and since its discovery in 1963 , surveys have been carried out in various regions of the world , where hepatoma is particularly prevalent , which have shown that alpha-fp may be detected in 50 to 80 % of patients with liver cancer .
C2239176
hepatocarcinoma
C0002210
alpha-fp